Update on tuberculosis: TB in the early 21st century

Eur Respir Rev. 2011 Jun;20(120):71-84. doi: 10.1183/09059180.00000511.
No abstract available

Publication types

  • Review

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Communicable Disease Control
  • Europe / epidemiology
  • Global Health
  • HIV Infections / epidemiology
  • Humans
  • Latent Tuberculosis* / diagnosis
  • Latent Tuberculosis* / drug therapy
  • Latent Tuberculosis* / epidemiology
  • Latent Tuberculosis* / prevention & control
  • Latent Tuberculosis* / transmission
  • Predictive Value of Tests
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Tuberculosis* / diagnosis
  • Tuberculosis* / drug therapy
  • Tuberculosis* / epidemiology
  • Tuberculosis* / prevention & control
  • Tuberculosis* / transmission
  • Tuberculosis, Multidrug-Resistant* / diagnosis
  • Tuberculosis, Multidrug-Resistant* / drug therapy
  • Tuberculosis, Multidrug-Resistant* / epidemiology
  • Tuberculosis, Multidrug-Resistant* / prevention & control
  • Tuberculosis, Multidrug-Resistant* / transmission

Substances

  • Antitubercular Agents